Posted by Clinical Lab Products | Apr 10, 2004 | Miscellaneous, POC Instruments |
By Isaac Meek Isaac Meek Many manufacturers, market participants, and analysts have characterized the growth of the point-of-care (POC) market as disappointing, because current market revenues fall well short of projections from 5 to 10 years ag
Read MorePosted by Clinical Lab Products | Apr 4, 2004 | Cerebrovascular, Miscellaneous |
By Lisa Fratt Aspirin is the frontline therapy used to protect patients from cardiovascular disease and stroke. In the United States alone, 25 million to 30 million people take aspirin on a daily basis to prevent cardiovascular disease and strok
Read MorePosted by Clinical Lab Products | Apr 2, 2004 | Cancer, Cerebrovascular, Miscellaneous, Stroke |
By Renee DiIulio Proteomics will soon enable speedy, sensitive, specific diagnosis of ischemic stroke. This will result in rapid treatment and improved outcomes for patients. “The future, for the general physician, lies in genomics, or anal
Read MorePosted by Clinical Lab Products | Apr 1, 2004 | Cancer, Miscellaneous |
New Products and Aggressive Initiatives Help Reference and Specialty Labs Boost Revenues
Read MorePosted by Clinical Lab Products | Mar 4, 2004 | Cerebrovascular, Miscellaneous |
Biomarkers at Bedside: i-STAT’s Point-of-Care Test Produces Cardiac Biomarker Troponin Results Withs
Read More